These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9147657)

  • 1. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Mol Membr Biol; 1996; 13(1):1-17. PubMed ID: 9147657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor.
    Arias HR
    J Neurosci Res; 1996 Apr; 44(2):97-105. PubMed ID: 8723217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
    Arias HR
    Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules.
    Arias HR
    J Neurosci Res; 1998 May; 52(4):369-79. PubMed ID: 9589382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1997 Jul; 1347(1):9-22. PubMed ID: 9233683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
    Lurtz MM; Hareland ML; Pedersen SE
    Biochemistry; 1997 Feb; 36(8):2068-75. PubMed ID: 9047305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists.
    Dilger JP; Vidal AM; Liu M; Mettewie C; Suzuki T; Pham A; Demazumder D
    Anesthesiology; 2007 Jun; 106(6):1186-95. PubMed ID: 17525594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor.
    Liu M; Dilger JP
    Mol Pharmacol; 2009 Jan; 75(1):166-73. PubMed ID: 18842832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
    Arias HR
    Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of nicotinic acetylcholine receptors.
    Chatzidaki A; Millar NS
    Biochem Pharmacol; 2015 Oct; 97(4):408-417. PubMed ID: 26231943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
    Chiara DC; Xie Y; Cohen JB
    Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of d-tubocurarine analogs with the Torpedo nicotinic acetylcholine receptor. Methylation and stereoisomerization affect site-selective competitive binding and binding to the noncompetitive site.
    Pedersen SE; Papineni RV
    J Biol Chem; 1995 Dec; 270(52):31141-50. PubMed ID: 8537377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of the polyamine binding site in the vestibule of the nicotinic acetylcholine receptor ion channel.
    Bixel MG; Weise C; Bolognesi ML; Rosini M; Brierly MJ; Mellor IR; Usherwood PN; Melchiorre C; Hucho F
    J Biol Chem; 2001 Mar; 276(9):6151-60. PubMed ID: 11104766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctions in agonist and antagonist specificity conferred by anionic residues of the nicotinic acetylcholine receptor.
    Osaka H; Sugiyama N; Taylor P
    J Biol Chem; 1998 May; 273(21):12758-65. PubMed ID: 9582301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural differences in the two agonist binding sites of the Torpedo nicotinic acetylcholine receptor revealed by time-resolved fluorescence spectroscopy.
    Martinez KL; Corringer PJ; Edelstein SJ; Changeux JP; Mérola F
    Biochemistry; 2000 Jun; 39(23):6979-90. PubMed ID: 10841780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist.
    Chiara DC; Trinidad JC; Wang D; Ziebell MR; Sullivan D; Cohen JB
    Biochemistry; 2003 Jan; 42(2):271-83. PubMed ID: 12525154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Ortells MO; Feuerbach D
    Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.